There have been 50 recent insider transactions recorded for Johnson & Johnson (JNJ), including 17 buys and 33 sells. Total insider buying was valued at $257.69K and total insider selling at $31.34M.
Notable insiders with recent activity include Hewson Marillyn A, Pinto Daniel E, Woods Eugene A.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — JNJ
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-10 |
Hewson Marillyn A |
Director |
RSU Award |
206 |
- |
- |
14,513 |
| 2026-03-10 |
Pinto Daniel E |
Director |
RSU Award |
129 |
- |
- |
462 |
| 2026-03-10 |
Woods Eugene A. |
Director |
RSU Award |
155 |
- |
- |
5,240 |
| 2026-02-27 |
Decker Robert J |
VP Corporate Controller |
Option Exercise (Sell) |
4,075 |
$115.67 |
$471.36K |
- |
| 2026-02-20 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Informative Sell |
1,322 |
$245.66 |
$324.76K |
25,447 |
| 2026-02-18 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
13,625 |
$115.67 |
$1.58M |
- |
| 2026-02-17 |
Reed John C |
EVP, Innovative Medicine, R&d |
Informative Sell |
2,283 |
$243.00 |
$554.77K |
10,658 |
| 2026-02-17 |
Wolk Joseph J |
Exec VP, CFO |
Option Exercise (Sell) |
19,241 |
$115.67 |
$2.23M |
- |
| 2026-02-17 |
Swanson James D. |
EVP, CIO |
Option Exercise (Sell) |
20,521 |
$164.62 |
$3.38M |
- |
| 2026-02-17 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
Informative Sell |
6,197 |
$243.39 |
$1.51M |
23,003 |
| 2026-02-15 |
Reed John C |
EVP, Innovative Medicine, R&d |
Option Exercise (Sell) |
1,349 |
- |
- |
1,349 |
| 2026-02-15 |
Duato Joaquin |
CEO and Chairman of the Board |
Option Exercise (Sell) |
3,682 |
- |
- |
3,682 |
| 2026-02-15 |
Wolk Joseph J |
Exec VP, CFO |
Option Exercise (Sell) |
1,971 |
- |
- |
1,971 |
| 2026-02-15 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
Option Exercise (Sell) |
1,594 |
- |
- |
1,594 |
| 2026-02-15 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
Option Exercise (Sell) |
606 |
- |
- |
606 |
| 2026-02-15 |
Decker Robert J |
VP Corporate Controller |
Option Exercise (Sell) |
339 |
- |
- |
338 |
| 2026-02-15 |
Swanson James D. |
EVP, CIO |
Option Exercise (Sell) |
492 |
- |
- |
491 |
| 2026-02-15 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
Option Exercise (Sell) |
492 |
- |
- |
491 |
| 2026-02-15 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
Option Exercise (Sell) |
961 |
- |
- |
961 |
| 2026-02-15 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
1,028 |
- |
- |
1,028 |
| 2026-02-15 |
Mulholland Kristen |
EVP, Chief HR Officer |
Option Exercise (Sell) |
419 |
- |
- |
418 |
| 2026-02-13 |
Duato Joaquin |
CEO and Chairman of the Board |
Option Exercise (Sell) |
73,054 |
- |
- |
- |
| 2026-02-13 |
Wolk Joseph J |
Exec VP, CFO |
Option Exercise (Sell) |
37,463 |
- |
- |
- |
| 2026-02-13 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
Option Exercise (Sell) |
1,302 |
- |
- |
- |
| 2026-02-13 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
Option Exercise (Sell) |
13,706 |
- |
- |
- |
| 2026-02-13 |
Decker Robert J |
VP Corporate Controller |
Option Exercise (Sell) |
312 |
- |
- |
- |
| 2026-02-13 |
Swanson James D. |
EVP, CIO |
Option Exercise (Sell) |
19,368 |
$165.89 |
$3.21M |
- |
| 2026-02-13 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
Option Exercise (Sell) |
408 |
- |
- |
- |
| 2026-02-13 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
Option Exercise (Sell) |
651 |
- |
- |
- |
| 2026-02-13 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
4,378 |
- |
- |
- |
| 2026-02-13 |
Mulholland Kristen |
EVP, Chief HR Officer |
Option Exercise (Sell) |
410 |
- |
- |
- |
| 2026-02-09 |
Duato Joaquin |
CEO and Chairman of the Board |
RSU Award |
73,054 |
- |
- |
73,054 |
| 2026-02-09 |
Wolk Joseph J |
Exec VP, CFO |
RSU Award |
37,463 |
- |
- |
37,463 |
| 2026-02-09 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
RSU Award |
27,412 |
- |
- |
27,412 |
| 2026-02-09 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
RSU Award |
13,706 |
- |
- |
13,706 |
| 2026-02-09 |
Decker Robert J |
VP Corporate Controller |
RSU Award |
2,741 |
- |
- |
2,741 |
| 2026-02-09 |
Swanson James D. |
EVP, CIO |
RSU Award |
9,412 |
- |
- |
9,412 |
| 2026-02-09 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
RSU Award |
8,594 |
- |
- |
8,594 |
| 2026-02-09 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
RSU Award |
13,706 |
- |
- |
13,706 |
| 2026-02-09 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
RSU Award |
4,378 |
- |
- |
4,378 |
| 2026-02-09 |
Mulholland Kristen |
EVP, Chief HR Officer |
RSU Award |
3,602 |
- |
- |
3,602 |
| 2026-02-06 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
Option Exercise (Sell) |
38,945 |
$101.87 |
$3.97M |
- |
| 2026-02-06 |
Mulholland Kristen |
EVP, Chief HR Officer |
Option Exercise (Sell) |
5,625 |
$101.87 |
$573.02K |
- |
| 2026-02-06 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
Option Exercise (Sell) |
15,571 |
$101.87 |
$1.59M |
- |
| 2026-02-05 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
Option Exercise (Sell) |
8,921 |
$129.51 |
$1.16M |
- |
| 2026-01-26 |
Duato Joaquin |
CEO and Chairman of the Board |
Informative Sell |
48,782 |
$221.48 |
$10.8M |
30,852 |
| 2025-12-09 |
Hewson Marillyn A |
Director |
RSU Award |
247 |
- |
- |
14,153 |
| 2025-12-09 |
Pinto Daniel E |
Director |
RSU Award |
155 |
- |
- |
331 |
| 2025-12-09 |
Woods Eugene A. |
Director |
RSU Award |
186 |
- |
- |
5,058 |
| 2025-11-26 |
Morikis John G |
Director |
Informative Buy |
1,250 |
$206.15 |
$257.69K |
1,849 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
